Analysis of ENG and ACVRL1 genes in 137 HHT Italian families identifies 76 different mutations (24 novel). Comparison with other European studies

Carla Olivieri, Fabio Pagella, Lucia Semino, Luca Lanzarini, Cristina Valacca, Andrea Pilotto, Sabrina Corno, Susi Scappaticci, Guido Manfredi, Elisabetta Buscarini, Cesare Danesino

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder causing vascular dysplasias. About 70-80% of HHT patients carries mutations in ENG or ACVRL1 genes, which code for a TGFβ receptor type III and I respectively. Molecular data on a large cohort of Italian HHT patients are presented, discussing the significance of missense and splice site mutations. Mutation analysis in ENG and ACVRL1 genes was performed using single strand conformation polymorphisms (SSCP), denaturing high performance liquid chromatography (DHPLC) and subsequent direct sequencing. Overall, 101 mutations were found, with ACVRL1 involved in 71% of cases. The highest number of mutations (28/101 subjects, 14/76 different mutations referring to both genes) was in ACVRL1, exon 3. Mutation analysis was then extended to a total of 356 family members, and 162 proven to carry the mutation. New polymorphisms were identified in both genes, and evidence that ENG P131L change is not a disease-causing mutation was also provided. An in silico analysis was performed in order to characterize splice-site mutations. These results were compared to other European national studies and data from Italy, France and Spain were consistent for an higher incidence of ACVRL1 mutations.

Original languageEnglish
Pages (from-to)820-829
Number of pages10
JournalJournal of Human Genetics
Volume52
Issue number10
DOIs
Publication statusPublished - Oct 2007

Fingerprint

Hereditary Hemorrhagic Telangiectasia
Mutation
Genes
Computer Simulation
Spain
Italy
France
Blood Vessels
Exons
High Pressure Liquid Chromatography

Keywords

  • ACVRL1 mutation
  • ENG mutation
  • Hereditary hemorrhagic telangiectasia
  • HHT

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Analysis of ENG and ACVRL1 genes in 137 HHT Italian families identifies 76 different mutations (24 novel). Comparison with other European studies. / Olivieri, Carla; Pagella, Fabio; Semino, Lucia; Lanzarini, Luca; Valacca, Cristina; Pilotto, Andrea; Corno, Sabrina; Scappaticci, Susi; Manfredi, Guido; Buscarini, Elisabetta; Danesino, Cesare.

In: Journal of Human Genetics, Vol. 52, No. 10, 10.2007, p. 820-829.

Research output: Contribution to journalArticle

Olivieri, Carla ; Pagella, Fabio ; Semino, Lucia ; Lanzarini, Luca ; Valacca, Cristina ; Pilotto, Andrea ; Corno, Sabrina ; Scappaticci, Susi ; Manfredi, Guido ; Buscarini, Elisabetta ; Danesino, Cesare. / Analysis of ENG and ACVRL1 genes in 137 HHT Italian families identifies 76 different mutations (24 novel). Comparison with other European studies. In: Journal of Human Genetics. 2007 ; Vol. 52, No. 10. pp. 820-829.
@article{86eb1e6ab85f4f1eaf56f74bdc3ce11b,
title = "Analysis of ENG and ACVRL1 genes in 137 HHT Italian families identifies 76 different mutations (24 novel). Comparison with other European studies",
abstract = "Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder causing vascular dysplasias. About 70-80{\%} of HHT patients carries mutations in ENG or ACVRL1 genes, which code for a TGFβ receptor type III and I respectively. Molecular data on a large cohort of Italian HHT patients are presented, discussing the significance of missense and splice site mutations. Mutation analysis in ENG and ACVRL1 genes was performed using single strand conformation polymorphisms (SSCP), denaturing high performance liquid chromatography (DHPLC) and subsequent direct sequencing. Overall, 101 mutations were found, with ACVRL1 involved in 71{\%} of cases. The highest number of mutations (28/101 subjects, 14/76 different mutations referring to both genes) was in ACVRL1, exon 3. Mutation analysis was then extended to a total of 356 family members, and 162 proven to carry the mutation. New polymorphisms were identified in both genes, and evidence that ENG P131L change is not a disease-causing mutation was also provided. An in silico analysis was performed in order to characterize splice-site mutations. These results were compared to other European national studies and data from Italy, France and Spain were consistent for an higher incidence of ACVRL1 mutations.",
keywords = "ACVRL1 mutation, ENG mutation, Hereditary hemorrhagic telangiectasia, HHT",
author = "Carla Olivieri and Fabio Pagella and Lucia Semino and Luca Lanzarini and Cristina Valacca and Andrea Pilotto and Sabrina Corno and Susi Scappaticci and Guido Manfredi and Elisabetta Buscarini and Cesare Danesino",
year = "2007",
month = "10",
doi = "10.1007/s10038-007-0187-5",
language = "English",
volume = "52",
pages = "820--829",
journal = "Journal of Human Genetics",
issn = "1434-5161",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Analysis of ENG and ACVRL1 genes in 137 HHT Italian families identifies 76 different mutations (24 novel). Comparison with other European studies

AU - Olivieri, Carla

AU - Pagella, Fabio

AU - Semino, Lucia

AU - Lanzarini, Luca

AU - Valacca, Cristina

AU - Pilotto, Andrea

AU - Corno, Sabrina

AU - Scappaticci, Susi

AU - Manfredi, Guido

AU - Buscarini, Elisabetta

AU - Danesino, Cesare

PY - 2007/10

Y1 - 2007/10

N2 - Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder causing vascular dysplasias. About 70-80% of HHT patients carries mutations in ENG or ACVRL1 genes, which code for a TGFβ receptor type III and I respectively. Molecular data on a large cohort of Italian HHT patients are presented, discussing the significance of missense and splice site mutations. Mutation analysis in ENG and ACVRL1 genes was performed using single strand conformation polymorphisms (SSCP), denaturing high performance liquid chromatography (DHPLC) and subsequent direct sequencing. Overall, 101 mutations were found, with ACVRL1 involved in 71% of cases. The highest number of mutations (28/101 subjects, 14/76 different mutations referring to both genes) was in ACVRL1, exon 3. Mutation analysis was then extended to a total of 356 family members, and 162 proven to carry the mutation. New polymorphisms were identified in both genes, and evidence that ENG P131L change is not a disease-causing mutation was also provided. An in silico analysis was performed in order to characterize splice-site mutations. These results were compared to other European national studies and data from Italy, France and Spain were consistent for an higher incidence of ACVRL1 mutations.

AB - Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder causing vascular dysplasias. About 70-80% of HHT patients carries mutations in ENG or ACVRL1 genes, which code for a TGFβ receptor type III and I respectively. Molecular data on a large cohort of Italian HHT patients are presented, discussing the significance of missense and splice site mutations. Mutation analysis in ENG and ACVRL1 genes was performed using single strand conformation polymorphisms (SSCP), denaturing high performance liquid chromatography (DHPLC) and subsequent direct sequencing. Overall, 101 mutations were found, with ACVRL1 involved in 71% of cases. The highest number of mutations (28/101 subjects, 14/76 different mutations referring to both genes) was in ACVRL1, exon 3. Mutation analysis was then extended to a total of 356 family members, and 162 proven to carry the mutation. New polymorphisms were identified in both genes, and evidence that ENG P131L change is not a disease-causing mutation was also provided. An in silico analysis was performed in order to characterize splice-site mutations. These results were compared to other European national studies and data from Italy, France and Spain were consistent for an higher incidence of ACVRL1 mutations.

KW - ACVRL1 mutation

KW - ENG mutation

KW - Hereditary hemorrhagic telangiectasia

KW - HHT

UR - http://www.scopus.com/inward/record.url?scp=34848865319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34848865319&partnerID=8YFLogxK

U2 - 10.1007/s10038-007-0187-5

DO - 10.1007/s10038-007-0187-5

M3 - Article

C2 - 17786384

AN - SCOPUS:34848865319

VL - 52

SP - 820

EP - 829

JO - Journal of Human Genetics

JF - Journal of Human Genetics

SN - 1434-5161

IS - 10

ER -